Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 44, 2009, Pages 18820-18824

  Patwardhan, Amol M ^a   Scotland, Phoebe E ^b   Akopian, Armen N ^a   Hargreaves, Kenneth M ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Inflammation; Pain

Indexed keywords

13 HYDROXYOCTADECADIENOIC ACID; 9 HYDROXYOCTADECADIENOIC ACID; LINOLEIC ACID; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ALLODYNIA; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HYPERALGESIA; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

ALPHA-LINOLENIC ACID; ANIMALS; BEHAVIOR, ANIMAL; CELL LINE; FREUND'S ADJUVANT; HYPERALGESIA; INFLAMMATION; ION CHANNEL GATING; LIGANDS; MALE; MEMBRANE POTENTIALS; MICE; OXIDATION-REDUCTION; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SPINAL CORD; TRPV CATION CHANNELS;

EID: 73249131229     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0905415106     Document Type: Article

References (34)

1. Caterina MJ, et al. (1997) The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389:816-824.
2. Cortright DN, Szallasi A (2004) Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem 271:1814-1819.
3. Mezey E, et al. (2000) Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 97:3655-3660.
4. Huang J, Zhang X, McNaughton PA (2006) Inflammatory pain: The cellular basis of heat hyperalgesia. Curr Neuropharmacol 4:197-206.
5. Tang L, et al. (2007) Antinociceptive pharmacology of N-(4-chlorobenzyl)-Ń-(4-hydroxy-3-iodo-5-methoxybenzyl) thiourea, a high-affinity competitive antagonist of the transient receptor potential vanilloid 1 receptor. J Pharmacol Exp Ther 321:791-798.
6. Kanai Y, Hara T, Imai A, Sakakibara A (2007) Differential involvement of TRPV1 receptors at the central and peripheral nerves in CFA-induced mechanical and thermal hyperalgesia. J Pharm Pharmacol 59:733-738.
7. Pitcher MH, Price TJ, Entrena JM, Cervero F (2007) Spinal NKCC1 blockade inhibits TRPV1-dependent referred allodynia. Mol Pain 3:17.
8. Cui M, et al. (2006) TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci 26:9385-9393.
9. Yoshida Y, Niki E (2006) Bio-markers of lipid peroxidation in vivo: Hydroxyoctadecadienoic acid and hydroxycholesterol. Biofactors 27:195-202.
10. Spiteller G (1998) Linoleic acid peroxidation-the dominant lipid peroxidation process in low density lipoprotein-and its relationship to chronic diseases. Chem Phys Lipids 95:105-162.
11. Gilchrist HD, Allard BL, Simone DA (1996) Enhanced withdrawal responses to heat and mechanical stimuli following intraplantar injection of capsaicin in rats. Pain 67:179-188.
12. Spindler SA, Clark KS, Callewaert DM, Reddy RG (1996) Significance and immunoassay of 9- and 13-hydroxyoctadecadienoic acids. Biochem Biophys Res Commun 218:187-191.
13. Bonnington JK, McNaughton PA (2003) Signaling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J Physiol 551:433-446.
14. Saria A, et al. (1986) Simultaneous release of several tachykinins and calcitonin generelated peptide from rat spinal cord slices. Neurosci Lett 63:310-314.
15. Zhang H, et al. (2007) Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: A novel pathway for heat hyperalgesia. J Neurosci 27:12067-12077.
16. Dirig DM, Konin GP, Isakson PC, Yaksh TL (1997) Effect of spinal cyclooxygenase inhibitors in rat using the formalin test and in vitro prostaglandin E2 release. Eur J Pharmacol 331:155-160.
17. Ben-Shabat S, et al. (1998)Anentourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharmacol 353:23-31.
18. Brinckmann R, et al. (1998) Membrane translocation of 15-lipoxygenase in hematopoietic cells is calcium-dependent and activates the oxygenase activity of the enzyme. Blood 91:64-74.
19. Kim HK, et al. (2006) Analgesic effect of vitamin E is mediated by reducing central sensitization in neuropathic pain. Pain 122:53-62.
20. Steiner AA, et al. (2007) Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors. J Neurosci 27:7459-7468.
21. Hwang SW, et al. (2000) Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances. Proc Natl Acad Sci USA 97:6155-6160.
22. Huang SM, et al. (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99:8400-8405.
23. Zygmunt PM, et al. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-457.
24. Yoshida Y, et al. (2007) Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers. Neurobiol Aging. 30:174-185.
25. Jira W, Spiteller G, Richter A (1997) Increased levels of lipid oxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis. Chem Phys Lipids 87:81-89.
26. Goodman Y, Steiner MR, Steiner SM, Mattson MP (1994) Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res 654:171-176.
27. van Heuven-Nolsen D, et al. (1995) Hypotensive effect of 13-hydroxylinoleic acid in the rat: Mediation via the release of a CGRP-like mediator from capsaicin-sensitive nerves. Br J Pharmacol 115:835-839.
28. Camp RD, et al. (1983) The identification of hydroxy fatty acids in psoriatic skin. Prostaglandins 26:431-447.
29. Obinata H, Hattori T, Nakane S, Tatei K, Izumi T (2005) Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of theGprotein-coupled receptor G2A. J Biol Chem 280:40676-40683.
30. Chinetti G, Fruchart JC, Staels B (2000) Peroxisome proliferator- activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49:497-505.
31. Starowicz K, Cristino L, Di Marzo V (2008) TRPV1 receptors in the central nervous system: Potential for previously unforeseen therapeutic applications. Curr Pharm Des 14:42-54.
32. Akopian AN, Ruparel NB, Jeske NA, HargreavesKM(2007) Transient receptor potential TRPA1 channel desensitization in sensory neurons is agonist dependent and regulated by TRPV1-directed internalization. J Physiol 583:175-193.
33. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63.
34. Scotland PE, Coderre TJ (2007) Enhanced 3,5-dihydroxyphenylglycine- induced sustained nociceptive behaviors in rats with neuropathy or chronic inflammation. Behav Brain Res 184:150-156.